Biocon Limited Schedules 48th Annual General Meeting for August 6, 2026; Reports Strong FY26 Performance
Published on: July 15, 2026, 10:56 p.m. | Source: scanx.trade
Biocon Limited has announced its 48th AGM for August 6, 2026 via VC/OAVM, with e-voting open from August 1 to August 5, 2026. Key agenda items include adoption of FY26 financial statements, declaration of a final dividend of ₹0.50 per equity share, re-appointment of Eric Vivek Mazumdar as Director, appointment of S.R. Batliboi & Associates LLP as new Statutory Auditors, and approval of the Biocon Unity Long Term Incentive Plan 2026 covering up to 4,35,00,000 equity shares. In FY26, Biocon reported consolidated operating revenue of ₹169,270 million (up 11% YoY), EBITDA of ₹37,978 million (up 25% on a like-to-like basis), and Net Profit of ₹3,856 million, alongside the completion of the full integration of Biocon Biologics Limited.
